Stockscreener 앱 받기
38.49
1.61%
0.61
시장 영업 전:
38.30
-0.19
-0.49%
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Top 5 Articles of the Week: November 16-21 - Dermatology Times
Is Pune Es Valuation Cheap Compared to Growth PeersChart Pattern Recognition & Superior Wealth Building - earlytimes.in
Castle Biosciences partners with SciBase for diagnostic tests - MSN
What Makes Castle Biosciences (CSTL) a New Strong Buy Stock - MSN
Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year HighTime to Buy? - MarketBeat
Castle Biosciences (CSTL) is on the Move, Here's Why the Trend Could be Sustainable - sharewise.com
Castle Biosciences stock hits 52-week high at $35.68 By Investing.com - Investing.com Canada
[Form 4] CASTLE BIOSCIENCES INC Insider Trading Activity - Stock Titan
Castle Biosciences stock hits 52-week high at $35.68 - Investing.com India
Can Castle Biosciences Inc. stock deliver consistent earnings growthJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
Castle Biosciences earns Houston Top Workplace title for fifth year - Traders Union
Castle Biosciences, Inc. (CSTL) Reports Next Week: Wall Street Expects Earnings Growth - MSN
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Castle Biosciences, Inc. (CSTL) Competitors - Meyka
Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year - The Manila Times
Zacks.com featured highlights include Perimeter Solutions, Interface, Castle Biosciences and Great Lakes Dredge & Dock - sharewise.com
Castle Biosciences (Nasdaq: CSTL) Receives 13 Top Workplaces and Culture Excellence Honors - Stock Titan
Castle Biosciences, Inc. $CSTL Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Will Castle Biosciences Inc. stock remain a Wall Street favorite2025 Volatility Report & Reliable Trade Execution Plans - newser.com
Castle Biosciences Inc. recovery potential after sell off2025 Biggest Moves & AI Driven Stock Reports - newser.com
Advisors Capital Management LLC Purchases 44,180 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Full technical analysis of Castle Biosciences Inc. stockEarnings Miss & Breakout Confirmation Alerts - newser.com
Is Castle Biosciences Inc. stock a dividend growth opportunity2025 Buyback Activity & Fast Gain Stock Trading Tips - newser.com
Quantitative breakdown of Castle Biosciences Inc. recent moveForecast Cut & Fast Exit/Entry Strategy Plans - newser.com
Is Castle Biosciences Inc a good long term investmentMarket Liquidity Analysis & High Profit Growth Stocks - earlytimes.in
Evaluating Castle Biosciences Inc. with trendline analysisPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Castle Biosciences melanoma test shows improved risk prediction By Investing.com - Investing.com Nigeria
[Form 4/A] CASTLE BIOSCIENCES INC Amended Insider Trading Activity - Stock Titan
Pattern recognition hints at Castle Biosciences Inc. upsideBond Market & Capital Efficient Trading Techniques - newser.com
Why Castle Biosciences Inc. stock could be next big winnerQuarterly Investment Review & AI Powered Buy and Sell Recommendations - Fundação Cultural do Pará
Castle Biosciences (CSTL) Showcases Breakthrough in Melanoma Tes - GuruFocus
Castle Biosciences melanoma test shows improved risk prediction - Investing.com
Castle Biosciences Announces Clinical Data Supporting DecisionDx-Melanoma's Role in Sentinel Lymph Node Biopsy Decision Making at ECDO 2025 - Quiver Quantitative
New Data Confirms Performance of DecisionDx®-Melanoma to - GlobeNewswire
Insider Sell: Frank Stokes Sells Shares of Castle Biosciences In - GuruFocus
Return on assets % of Castle Biosciences, Inc. – FWB:086 - TradingView
Chart based analysis of Castle Biosciences Inc. trends2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
Zacks.com featured highlights include Castle Biosciences, Perimeter Solutions, South Atlantic Bancshares and Astronics - sharewise.com
Castle Biosciences, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:CSTL) 2025-11-12 - Seeking Alpha
COO Oelschlager Files To Sell 18,932 Of Castle Biosciences Inc [CSTL] - TradingView
Acadian Asset Management LLC Has $11.11 Million Stock Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Reaches New 52-Week HighHere's Why - MarketBeat
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Is Castle Biosciences Ready To Turn Stability Into Growth? - RTTNews
0.35%
1.41%
자본화:
|
볼륨(24시간):